EcoDrugPlus

Ensembl ID : ENSOMYG00000009125
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSOMYG00000009178
Gene Symbol: -
Cross references: -
334 Possible Orthologues:

Ensembl ID : ENSOMYG00000009350
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSOMYG00000009596
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSOMYG00000010107
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSOMYG00000009566
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000010249
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000009530
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSOMYG00000011201
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOMYG00000009526
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOMYG00000009416
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSOMYG00000011158
Gene Symbol: -
Cross references: -
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).